Comparative Study to Evaluate the Efficacy and Safety of MYL-1701P and Eylea® in Subjects With Diabetic Macular Edema (DME)
Public ClinicalTrials.gov record NCT03610646. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi Center, Randomized, Double-Masked, Active-Controlled, Comparative Clinical Study to Evaluate the Efficacy and Safety of MYL-1701P and Eylea® in Subjects With Diabetic Macular Edema (DME)
Study identification
- NCT ID
- NCT03610646
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Mylan Pharmaceuticals Inc
- Industry
- Enrollment
- 355 participants
Conditions and interventions
Conditions
Interventions
- Eylea Drug
- MYL-1701P Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 22, 2018
- Primary completion
- Nov 9, 2020
- Completion
- Sep 9, 2021
- Last update posted
- Mar 6, 2023
2018 – 2021
United States locations
- U.S. sites
- 13
- U.S. states
- 11
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mylan Investigator Site | Phoenix | Arizona | 85014 | — |
| Mylan Investigator Site | Phoenix | Arizona | 85020 | — |
| Mylan Investigator Site | Sacramento | California | 95841 | — |
| Mylan Investigator Site | St. Petersburg | Florida | 33711 | — |
| Mylan Investigator Site | Winter Haven | Florida | 33880 | — |
| Mylan Investigator Site | Augusta | Georgia | 30909 | — |
| Mylan Investigator Site | Shawnee Mission | Kansas | 66204 | — |
| Mylan Investigator Site | Paducah | Kentucky | 42001 | — |
| Mylan Investigator Site | Chevy Chase | Maryland | 20815 | — |
| Mylan Investigator Site | Ladson | South Carolina | 29456 | — |
| Mylan Investigator Site | Nashville | Tennessee | 37203 | — |
| Mylan Investigator Site | Abilene | Texas | 79606 | — |
| Mylan Investigator Site | Morgantown | West Virginia | 26506 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 60 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03610646, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 6, 2023 · Synced May 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03610646 live on ClinicalTrials.gov.